PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM) ...Middle East

PR Newswire - News
PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM)
ALLEGAN, Mich., April 28, 2023 /PRNewswire/ -- Padagis today announced the launch of Budesonide 2mg Rectal Foam (generic to Uceris®) with 180-days of Competitive Generic Therapy exclusivity. Uceris® is a prescription corticosteroid medicine used to help get active, mild to moderate...

Read More Details
Finally We wish PressBee provided you with enough information of ( PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM) )

Also on site :



Latest News